ID

16057

Description

Documentation part: Log Status & Randomisation Number A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Mots-clés

Versions (1)
  1. 27/06/2016 27/06/2016 -
Téléchargé le

27 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Anglais

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulaires  
Log Status
Description

Log Status

Did the subject experience any adverse events during the study?
Description

Did the subject experience any adverse events during the study?

Type de données

text

Alias
UMLS CUI [1]
C0877248
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Description

Were any concomitant medications taken by the subject prior to screening and/or during the study?

Type de données

text

Alias
UMLS CUI [1]
C2347852
Case book ready for signature
Description

CRA should check the box when data cleaning is complete. This item is used for Phase I trials only. Remove for Phase II-IV

Type de données

text

Alias
UMLS CUI [1]
C1519316
For inform only: Do not data enter
Description

For inform only: Do not data enter

Q1
Description

Q1

Type de données

text

Q2
Description

Q2

Type de données

text

Randomisation Number (RAND)
Description

Randomisation Number (RAND)

Randomisation number
Description

Randomisation number

Type de données

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C0034656
Retour au début de la page

Similar models

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Log Status
Item
Did the subject experience any adverse events during the study?
text
C0877248 (UMLS CUI [1])
Did the subject experience any adverse events during the study?
Code List
Did the subject experience any adverse events during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
text
C2347852 (UMLS CUI [1])
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Code List
Were any concomitant medications taken by the subject prior to screening and/or during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Case book ready for signature
text
C1519316 (UMLS CUI [1])
Case book ready for signature
Code List
Case book ready for signature
CL Item
Yes (Y)
Item Group
For inform only: Do not data enter
Item
Q1
text
Q1
Code List
Q1
CL Item
Yes (Y)
CL Item
No (N)
Item
Q2
text
Q2
Code List
Q2
CL Item
PF_SC_LOST (1)
CL Item
PF_SC_DEATH (2)
CL Item
PF_SC_SPONSORDECISlON (3)
CL Item
PF_SC_PHYS[ClANDEClSlON (4)
CL Item
PF_SC_PATIENTDEClSION (5)
CL Item
PF_SC_AE (6)
CL Item
PF_SC_CRlTERIA (7)
CL Item
PF_SC_OTHER (8)
Item Group
Randomisation Number (RAND)
Randomisation number
Item
Randomisation number
integer
C0449788 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial